2 completed, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow VB4-845: new trials by email Literature Review of VB4-845 trials Research Report on VB4-845
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer VB4-845 Injection - Non-Muscle Invasive Bladder Cancer | Phase 3 | Unknown | Qilu Pharmaceutical Co., Ltd. | 53 | 2021-03-23 | 2021-04-26 |
| Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Vicinium - Bladder Cancer | Phase 3 | Completed | Sesen Bio, Inc. | 133 | 2015-08-01 | 2023-07-24 |
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ Vicinium - Urinary Bladder Cancer, Bladder Cancer | Phase 2 | Completed | Sesen Bio, Inc. | 46 | 2007-03-01 | 2020-05-12 |
Non-Muscle Invasive Bladder Neoplasms (2) · Urinary Bladder Neoplasms (2)
Sesen Bio, Inc. (2) · Qilu Pharmaceutical Co., Ltd. (1)
Canada (2) · United States (2) · China (1)
Dingwei Ye, PI (1) · Minori K Rosales, M.D., Ph.D. (1) · Wendy Chapman (1)